EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteasomal regulation of ASK family kinases dictates cell fate under hyperosmotic stress

Xiangyu Zhou, Kengo Watanabe, Kazuhiro Morishita, Jun Hamazaki, Shigeo Murata, Isao Naguro, Hidenori Ichijo

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Xiangyu Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Osmotic Pressure, MAP Kinase Kinase Kinase 5. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The proteasome has an essential role in proteostasis maintenance and is critical for cell survival under proteotoxic conditions, including hyperosmotic stress. However, how proteasome activity is linked to cell survival/death under hyperosmotic stress is unclear. We previously reported that apoptosis signal-regulating kinase 3 (ASK3) contributes to cell survival through its inactivation under hyperosmotic stress. The 19S regulatory particle subunits of the proteasome were enriched in the ASK3 inactivator candidates identified through our genome-wide siRNA screening. In this study, we demonstrated that the proteasome regulates ASK3 inactivation through its proteolytic activity. Intriguingly, the proteasome inactivates ASK3 via degradation of not ASK3 per se but another ASK family member, ASK1, which activates ASK3 in a kinase activity-dependent manner. Furthermore, elevated ASK1 levels under proteasome inhibition sensitize cells to hyperosmotic stress. These findings suggest that ASK family kinases function as key mediators linking proteasome capacity to cellular susceptibility under hyperosmotic stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteasome Endopeptidase ComplexOsmotic PressureMAP Kinase Kinase Kinase 5HumansProteolysisApoptosisCell SurvivalHEK293 Cells

Stichwörter der Autor:innen

apoptosis signal-regulating kinase 1apoptosis signal-regulating kinase 3high-content genome-wide siRNA screeninghyperosmotic stressproteasomeproteotoxicity

Substanzen

Proteasome Endopeptidase ComplexMAP Kinase Kinase Kinase 5MAP3K5 protein, human

Autor:innen und Institutionen

  • Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
  • Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. Electronic address: ken5watanabe@tokushima-u.ac.jp.
  • Laboratory of Protein Metabolism, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • Japan Agency for Medical Research and Development

Zitieren

APA

Zhou, X., Watanabe, K., Morishita, K., Hamazaki, J., Murata, S., Naguro, I., & Ichijo, H. (2025). Proteasomal regulation of ASK family kinases dictates cell fate under hyperosmotic stress. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110566

Vancouver

Zhou X, Watanabe K, Morishita K, Hamazaki J, Murata S, Naguro I, et al. Proteasomal regulation of ASK family kinases dictates cell fate under hyperosmotic stress. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110566

BibTeX
@article{Zhou2025,
  author = {Zhou, Xiangyu and Watanabe, Kengo and Morishita, Kazuhiro and Hamazaki, Jun and Murata, Shigeo and Naguro, Isao and Ichijo, Hidenori},
  title = {Proteasomal regulation of ASK family kinases dictates cell fate under hyperosmotic stress},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110566}
}
Kostenlos starten →